Vanessa Milogiannakis is a first year PhD candidate at The Kirby Institute UNSW, researching the development of novel assay platforms to study emerging viruses.

Dr Rebecca Rockett is a molecular microbiologist and leader in genomic epidemiology. Her research focuses on utilising genomics to detect and characterise a range of existing and emerging infectious diseases to improve healthcare outcomes. In 2020 she led the implementation of SARS-CoV-2 genomics in Australia, which was principle to public health interventions to contains COVID-19 transmission. Dr Rockett is a Senior Lecturer at the School of Medical Sciences, University of Sydney and holds and NHMRC Emerging Leader Investigator grant.

Dr Larisa Labzin leads the Viruses and Innate Immunity group at the Institute for Molecular Bioscience, UQ. Dr Labzin obtained her PhD in 2015 from the University of Bonn, Germany and undertook postdoctoral training at the MRC-Laboratory of Molecular Biology in Cambridge, UK. She returned to Australia in 2019 to study how viruses trigger inflammation.

Dr. Rhys Parry is a molecular virologist in Prof Alexander Khromykh's lab at the University of Queensland specializing in the study of SARS-CoV-2. His work leverages a combination of reverse genetics, phylogenetic analysis, and traditional wet lab virology to uncover molecular determinants of infection and vaccination effectiveness.

Dr Andrii Slonchak is a research fellow at RNA Virology Laboratory (School of Chemistry and Molecular Biosciences, University of Queensland). In his research he uses systems biology approaches, which employs advanced infection models and integrates transcriptomics and computational biology with classical virology techniques to study virus-host interaction.